US2022079999A1PendingUtilityA1
Antivenom compositions and uses thereof
Est. expiryMay 24, 2036(~9.8 yrs left)· nominal 20-yr term from priority
Inventors:Donald A. Schultz
A61K 35/583
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed herein are compositions and methods for treating a victim of a venomous snakebite. Antivenom compositions are prepared from snake plasma or from snake eggs. The antivenom compositions are able to neutralize a snake venom from an autologous snake. The antivenom compositions can be administered to a snakebite victim to treat or prevent the pathological effects of a venomous snakebite.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A composition comprising a combination of plasma from two or more snake species, wherein each snake species is different and each snake species is a venomous snake species.
2 . The composition of claim 1 , wherein the combination of plasma is from a first and a second snake species.
3 . The composition of claim 2 , wherein the combination of plasma is in a ratio of the volume of plasma from the first snake species to the volume of plasma from the second snake species ranging from about 1:1 to about 10:1.
4 . The composition of claim 2 , wherein the ratio of the volume of plasma from the first snake species to the volume of plasma from the second snake species is about 1:1, about 2:1, about 3:1, about 4:1, about 5:1, about 6:1, about 7:1, about 8:1, about 9:1, or 10:1.
5 . The composition of claim 4 , wherein the ratio of the volume of plasma from the first snake species to the volume of plasma from the second snake species is about 3:1.
6 . The composition of claim 1 , wherein at least one of the snake species is a member of the genus Lampropeltis sp, Drymarchon sp, Boiruna sp or Gonionotophis sp.
7 . The composition of claim 5 , wherein the first snake species is a Python species and the second snake species is a Lampropeltis species.Join the waitlist — get patent alerts
Track US2022079999A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.